Frequent Links
Top JournalscellsMelanoma Online JournalsUrologyThyroid therapy articlesexecutive management impact factordefense impact factorrisk-management-peer-review-journalschild abuseSoil Organic Carbonpharmaceutical regulatory affairs Open access articlesBio-pharmaceuticsMigraine Peer-review JournalsAquaculture-Top-Open-Access-JournalsPreeclampsia
Bevantolol
240px | |
Systematic (IUPAC) name | |
---|---|
(RS)-[2-(3,4-dimethoxyphenyl)ethyl][2-hydroxy-3-(3-methylphenoxy)propyl]amine | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
| |
Oral | |
Identifiers | |
59170-23-9 7px | |
C07AB06 | |
PubChem | CID 2372 |
DrugBank | DB01295 7px |
ChemSpider | 2282 7px |
UNII | 34ZXW6ZV21 7px |
ChEBI | CHEBI:238698 7px |
ChEMBL | CHEMBL314010 7px |
Chemical data | |
Formula | C20H27NO4 |
345.43 g/mol | |
| |
14px (what is this?) (verify) |
Bevantolol (INN) is a drug that acts as both a beta blocker and a calcium channel blocker.[1]
References
- ^ Warltier DC, Gross GJ, Jesmok GJ, Brooks HL, Hardman HF (1980). "Protection of Ischemic Myocardium: Comparison of Effects of Propranolol, Bevantolol and N-Dimethyl Propranolol on Infarct Size Following Coronary Artery Occlusion in Anesthetized Dogs". Cardiology 66.
|
Lua error in package.lua at line 80: module 'Module:Buffer' not found.
Lua error in package.lua at line 80: module 'Module:Buffer' not found.